Abu-Tair F, Strowitzki T, Bergemann N
Klinik für Allgemeine Psychiatrie, Zentrum für Psychosoziale Medizin, Universitätsklinikum Heidelberg, 69115 Heidelberg.
Nervenarzt. 2007 Jun;78(6):691-2, 694-5. doi: 10.1007/s00115-007-2276-2.
Leuproreline acetate is a gonadotropin-releasing hormone (GnRH) analog which is used for in vitro fertilization (IVF) treatment. This compound suppresses gonadal estrogen secretion prior to hormonal stimulation. We report a 37-year-old woman who suffered from a schizoaffective psychosis for several years. She received IVF treatment with leuproreline acetate (Uno-Enantone) because of primary infertility. Under this treatment she developed acute schizoaffective symptoms. Suppression of gonadal secretion can result in exacerbation of schizophrenic psychosis, which is in line with the hypothesis of protective effects of estrogen in schizophrenia. We recommend that IVF treatment with leuproreline acetate in patients with psychiatric disorders be initiated only with special attention to their mental condition. In addition, patients should be informed about the possible mental effects of the treatment.
醋酸亮丙瑞林是一种促性腺激素释放激素(GnRH)类似物,用于体外受精(IVF)治疗。该化合物在激素刺激前抑制性腺雌激素分泌。我们报告一名37岁患有分裂情感性精神病数年的女性。由于原发性不孕症,她接受了醋酸亮丙瑞林(抑那通)的IVF治疗。在此治疗期间,她出现了急性分裂情感症状。性腺分泌的抑制可导致精神分裂症性精神病加重,这与雌激素在精神分裂症中的保护作用假说相符。我们建议,仅在特别关注精神状况的情况下,才对患有精神疾病的患者启动醋酸亮丙瑞林的IVF治疗。此外,应告知患者该治疗可能产生的精神影响。